Department of Radiology, UT Southwestern Medical Center, Dallas, TX, USA; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA.
Department of Radiology, UT Southwestern Medical Center, Dallas, TX, USA.
Magn Reson Imaging. 2023 Dec;104:80-87. doi: 10.1016/j.mri.2023.09.009. Epub 2023 Sep 26.
To evaluate different approaches for the effective assessment of pulmonary perfusion with a pseudo-continuous arterial spin labeled (pCASL) MRI.
Four different approaches were evaluated: 1) Cardiac-triggered inferior vena cava (IVC) labeling; 2) IVC labeling with cardiac-triggered acquisition; 3) Right pulmonary artery (RPA) labeling with cardiac-triggered acquisition; and 4) Cardiac-triggered RPA labeling with background suppression (BGS). Each approach was evaluated in 5 healthy volunteers (n = 20) using coefficient of variation (COV) across averages. Approach 4 was also compared against a flow alternating inversion recovery (FAIR).
The IVC labeling (Approach 1) achieved perfusion-weighted images of both lungs, although this approach was more sensitive to variations in heart rate. Cardiac-triggered acquisitions using IVC (Approach 2) and RPA (Approach 3) labeling improved signal consistencies, but were incompatible with BGS. The cardiac-triggered RPA labeling with BGS (Approach 4) achieved a COV of 0.34 ± 0.03 (p < 0.05 compared to IVC labeling approaches) and resulted in perfusion value of 434 ± 64 mL/100 g/min, which was comparable to 451 ± 181 mL/100 g/min measured by FAIR (p = 0.82).
Pulmonary perfusion imaging using pCASL-MRI is highly sensitive to cardiac phase, and requires approaches to minimize flow-induced signal variations. Cardiac-triggered RPA labeling with BGS achieves reduced COV and enables robust pulmonary perfusion imaging.
评估伪连续动脉自旋标记(pCASL)MRI 评估肺灌注的不同方法。
评估了四种不同的方法:1)心脏触发下腔静脉(IVC)标记;2)心脏触发采集下的 IVC 标记;3)心脏触发采集下的右肺动脉(RPA)标记;4)带背景抑制(BGS)的心脏触发 RPA 标记。在 5 名健康志愿者(n=20)中,使用平均值的变异系数(COV)评估了每种方法。方法 4 还与流动交替反转恢复(FAIR)进行了比较。
IVC 标记(方法 1)实现了双肺的灌注加权图像,但该方法对心率变化更敏感。使用 IVC(方法 2)和 RPA(方法 3)标记的心脏触发采集提高了信号一致性,但与 BGS 不兼容。带 BGS 的心脏触发 RPA 标记(方法 4)达到了 0.34±0.03 的 COV(与 IVC 标记方法相比,p<0.05),并得出了 434±64mL/100g/min 的灌注值,与 FAIR 测量的 451±181mL/100g/min 相当(p=0.82)。
使用 pCASL-MRI 进行肺灌注成像对心脏相位非常敏感,需要采用方法来最小化血流引起的信号变化。带 BGS 的心脏触发 RPA 标记可降低 COV,实现稳健的肺灌注成像。